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Spectra of Chromosomal Aberrations in 325 Leukemia Patients 
and Implications for the Development of New Molecular 
Detection Systems
This study investigated the spectrum of chromosomal abnormalities in 325 leukemia 
patients and developed optimal profiles of leukemic fusion genes for multiplex RT-PCR. We 
prospectively analyzed blood and bone marrow specimens of patients with acute leukemia. 
Twenty types of chromosomal abnormalities were detected in 42% from all patients by 
commercially available multiplex RT-PCR for detecting 28 fusion genes and in 35% by 
cytogenetic analysis including FISH analysis. The most common cytogenetic aberrations in 
acute myeloid leukemia patients was PML/PARA, followed by AML1/MGT8 and MLL1, and 
in acute lymphoid leukemia patients was BCR/ABL, followed by TEL/AML1 and MLL1 gene 
rearrangement. Among the negative results for multiplex RT-PCR, clinically significant 
t(3;3)(q21;q26.2), t(8;14)(q24;q32) and i(17)(q10) were detected by conventional 
cytogenetics. The spectrum and frequency of chromosomal abnormalities in our leukemia 
patients are differed from previous studies, and may offer optimal profiles of leukemic 
fusion genes for the development of new molecular detection systems.
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ORIGINAL ARTICLE
Oncology & Hematology
INTRODUCTION
 
Cytogenetic aberrations in hematologic malignancies can be 
assayed by a variety of methods. Commonly used methods are 
conventional cytogenetics, fluorescence in situ hybridization 
(FISH), and multiplex reverse transcriptase polymerase chain 
reaction (RT-PCR) systems. Especially, Pallisgaard et al. have pre-
sented a multiplex RT-PCR system that allows simultaneous de-
tection of 29 fusion genes and more than 80 breakpoints and 
splice variants in patients with acute leukemia (1). Since then, a 
commercially available multiplex RT-PCR system (HemaVision, 
DNA technology, Aarhus, Denmark), a similar modified assay, 
to detect 28 fusion genes in patients with acute myeloid leuke-
mia (AML) and acute lymphoid leukemia (ALL) has been de-
veloped.
  Chromosomal abnormalities occur in approximately 56% of 
de novo AML in adults and slightly more frequently in children 
(2-4). At present, more than 50 different consistently occurring 
translocations have been described, many of which have been 
found to be specific for particular subtypes of leukemia or lym-
phoma (1). To date, most of the data reported were from west-
ern countries. Racial differences in various hematological ma-
lignancies were previously reported between Asian and western 
countries (5). It is important, therefore, to investigate and char-
acterize the karyotypic pattern in any geographically restricted 
population of patients, so that identification of cytogenetic risk 
factors can be used in current risk-adapted chemotherapy for 
acute leukemia. 
  The current study was undertaken to investigate spectra of 
chromosomal aberrations and diagnostic values of recently de-
veloped commercial multiplex RT-PCR system in 325 leukemia 
patients, and then to recommend a panel of leukemic fusion 
genes suitable for the development of new efficient molecular 
detection systems.http://jkms.org   887
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MATERIALS AND METHODS
Patients
We examined 325 leukemia patients during a 4-yr period (2006-
2009). Eighty-one children (median age 8 yr, range 0-18 yr) and 
244 adults (median age 56 yr, range 19-86 yr) were included in 
the study. Of the 81 children, 35 (43%) were male and 46 (57%) 
were female; of the 244 adults, 123 (50%) were male. A total of 
213 (66%) were diagnosed as de novo (92%) or secondary (8%) 
AML (23 children, 190 adults); 104 (32%) were of ALL (55 chil-
dren, 49 adults); and 8 were of mixed phenotype acute leukemia 
(MPAL) (Table 1). 
Conventional cytogenetic analysis
Chromosome analysis was performed after short-term cultur-
ing without mitogens. The chromosome aberrations were de-
scribed according to the International System for Cytogenetic 
Nomenclature 2005 and 2009. A patient was classified as having 
a normal karyotype only after 20 normal metaphases were ana-
lyzed (Fig. 1).
Multiplex RT-PCR system
RNA was extracted from peripheral blood or bone marrow us-
ing an RNAqueous Kit (Ambion, Austin, TX, USA) according to 
the manufacturer’s protocol (Supplemental Fig. 1). The Hema-
Vision multiplex RT-PCR Screen Test kit (DNA Technology, Aar-
hus, Denmark) detects 28 of the most common leukemic fusion 
genes and more than 80 splice variants. In brief, reverse tran-
scription was performed with a mixture of translocation-specif-
ic primers. PCR amplification was performed in 2 steps: a mas-
ter PCR amplification followed by nested PCR which screened 
for the presence of fusion transcripts and a split-out PCR ampli-
fication followed by nested PCR which identified the specific 
fusion transcript(s). Each of the 8 parallel nested multiplex mas-
ter PCR reactions contained a mixture of primer pairs for the 
detection of several fusion transcripts and 2 primer pairs for an 
internal control gene product of 911 base pairs (Fig. 1). When 
the presence of one or more fusion transcripts was detected by 
one or more master PCR reactions, the corresponding split-out 
reactions with individual primer pairs were performed.
Fluorescence in situ hybridization
In additional to conventional cytogenetic analysis, FISH was ap-
plied in appropriate bone marrow or peripheral blood speci-
mens available from 275 patients. FISH was performed with the 
Vysis LSI probe (Abbott Molecular/Vysis, Des Plaines, IL, USA) 
according to the manufacturer’s instructions. 
Table 1. Distribution of disease and participating patients
Disease Adult Children Total
AML
   de novo
   secondary
 
175
  15
 
22
  1
 
197
  16
ALL
   Early preB cell type 
   PreB cell type 
   B cell type
   T cell type
 
    7
  26
    5
  11
 
  5
37
  5
  8
 
  12
  63
  10
  19
Mixed phenotype acute leukemia     5   3     8
No. of cases 244 81 325
AML, acute myeloid leukemia; ALL, acute lymphoid leukemia.
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Fig. 1. Representative chromosomal 
abnormalities. (A) Cryptic cytogenetic 
abnormalities were detected only in the 
multiplex RT-PCR system, which usually 
disclosed normal karyotype by conven-
tional cytogenetic analysis. Positive band 
at 174base pair (arrow) in master PCR 
step turned out TEL/AML1 gene rear-
rangement by split out multiplex RT-
PCR. (B) Some chromosomal abnormal-
ities such as t(3;3) or t(8;14) should be 
included in multiplex RT-PCR system, 
which were not covered in the commer-
cially available multiplex RT-PCR sys-
tem. Arrows indicated t(3;3)(q21;q26.2). 
M, molecular weight marker.888   http://jkms.org
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Ethics statement
This study was reviewed and approved by the institutional re-
view board of Chonnam National University Hwasun Hospital 
(IRB No. 2009-35). Informed consent was obtained from all of 
the participating patients in the present study.
RESULTS
Chromosomal aberrations detected by multiplex RT-PCR 
system
Twenty types of chromosomal aberrations in 28 fusion genes 
were detected in 42% of the total patients by multiplex RT-PCR 
system (Table 2). The multiplex RT-PCR analysis detected fusion 
transcripts in 39% (83/213) of the AML patients and in 50% of 
the ALL patients, in 50% of the MPAL patients (Table 3). 
Chromosomal aberrations by AML and ALL groups 
Within the group of 213 AML patients, the following fusion tran-
scripts were detected: 35 PML/PARA, 31 AML1/MGT8, 7 MLL1 
rearrangement, 3 CBFB/MYH11, 2 SET/CAN, one of each BCR/
ABL, TEL/ABL, AML1/MDS1, PLZF/RARA, TEL/MN1 and TLS/ 
ERG. One child patient with acute leukemic conversion from 
chronic myeloid leukemia (CML) had simultaneously two fu-
sion transcripts (BCR/ABL and SET/CAN).
  In the group of 104 ALL patients, fusion transcripts were de-
tected in 21 BCR/ABL, 15 TEL/AML1, 9 MLL1 including 5 MLL1/ 
AF4, 2 MLL1/AF6, one of each of MLL1/AF9 and MLL1/ENL, 4 
E2A/PBX, one of each of TEL/ABL, TEL/ABL and SIL1/TAL1. In 
the eight patients of the MPAL group, the fusion transcripts were 
Table 2. Frequency of genetic aberrations by age group in patients with hematologic 
malignancies detected by multiplex RT-PCR system
Genetic rearrangement by  
   multiplex RT-PCR*
Adults  
(n = 244)
Children  
(n = 81)
Total  
(n = 325)
t(15;17)(q21;q22)   PML/RARa  31   4 35
t(9;22)(q34;q11)  BCR/ABL  20   5 25
t(8;21)(q22;q22)   AML1/MGT8   24    7
†   31
†
11q23
   t(4;11)(q21.2;q23.2)
   t(6;11)(q27;q23)
   t(11;19)(q23;p13.1) 
   t(1;11)(p32;q23)
   t(9;11)(p22;q23)
   t(10;11)(p12;q23)
   t(11;19)(q23;p13.3)
 
MLL1/AF4
MLL1/AF6
MLL1/ELL
MLL1/AF-1p
MLL1/AF9
MLL1/AF10
MLL1/ENL
 
  2
  3
  3
  1
  1
  1
 
  
  3
  1
  1
 
 
 
  1
17
(5)
(4)
(4)
(1)
(1)
(1)
(1)
t(12;21)(p13;q22)   TEL/AML1   1 14 15
t(1;19)(q23;p13) E2A/PBX   4   4
inv(16)(p13;q22) CBFb/MYH11   3   3
t(9;9)(q34:q34) SET/CAN   2    1
†    3
†
t(9;12)(q34;p13) TEL/ABL   2   2
del(1p34) SIL1/TAL1   1   1
t(3;21)(q26;q22) AML1/MDS1   1   1
t(11;17)(q23;q21) PLZF/RARA   1   1
t(12;22)(p13;q11) TEL/MN1   1   1
t(16;21)(p11.2;q22.3) TLS/ERG   1   1
No. of positive cases (%)   96 (39)   43
† (53)  139
† (42)
*Hemavision multiplex RT-PCR screening system; 
†Two fusion transcripts (BCR/ABL 
and SET/CAN) were detected by multiplex RT-PCR system in one sample.
Table 3. Frequency of genetic aberrations by type of hematological malignancy in all 
patients detected by multiplex RT-PCR system
Genetic rearrangement detected by  
   multiplex RT-PCR 
AML  
(n = 213)
ALL  
(n = 104)
MPAL  
(n = 8) 
t(15;17)(q21;q22)   PML/RARa  35
t(9;22)(q34;q11)  BCR/ABL     1* 21 3
t(8;21)(q22;q22)   AML1/MGT8   31
11q23
   t(4;11)(q21.2;q23.2)
   t(6;11)(q27;q23)
   t(11;19)(q23;p13.1) 
   t(1;11)(p32;q23)
   t(9;11)(p22;q23)
   t(10;11)(p12;q23)
   t(11;19)(q23;p13.3)
 
MLL1/AF4
MLL1/AF6
MLL1/ELL
MLL1/AF-1p
MLL1/AF9
MLL1/AF10
MLL1/ENL
 
 
  2
  3
  1
 
  1
  
 
  5
  2
 
 
  1
 
  1
 
 
 
1
 
 
 
 
t(12;21)(p13;q22)   TEL/AML1   15  
t(1;19)(q23;p13) E2A/PBX   4
inv(16)(p13;q22) CBFb/MYH11   3
t(9;9)(q34:q34) SET/CAN    2*   1
t(9;12)(q34;p13) TEL/ABL   1   1
del(1p34) SIL1/TAL1   1
t(3;21)(q26;q22) AML1/MDS1   1
t(11;17)(q23;q21) PLZF/RARA   1
t(12;22)(p13;q11) TEL/MN1   1
t(16;21)(p11.2;q22.3) TLS/ERG   1
No. of positive cases (%) 83 (39) 52 (50) 4 (50)
*Two fusion transcripts were detected by multiplex RT-PCR system in one sample.
Table 4. Distribution of chromosomal aberrations in participating patients detected 
by conventional karyotyping including FISH
Chromosome aberrations AML  
(n = 213)
ALL  
(n = 104)
MPAL  
(n = 8)
Total  
(n = 325)
t(15;17)(q21;q22)   PML/RARa  28 28
t(8;21)(q22;q22)   AML1/MGT8   28 28
t(9;22)(q34;q11)  BCR/ABL  17 3 20
t(4;11)(q21.2;q23.2) MLL1/AF4   4   4
t(6;11)(q27;q23) MLL1/AF6   1   1
t(11;19)(q23;p13.1)  MLL1/ELL   1   1
t(9;11)(p22;q23) MLL1/AF9   1   1
t(12;21)(p13;q22)   TEL/AML1   1   1
t(1;19)(q23;p13) E2A/PBX   1   1
inv(16)(p13;q22) CBFb/MYH11   2   2
del(1p34) SIL/TAL   1   1
t(3;21)(q26;q22) AML1/MDS1   1   1
t(11;17)(q23;q21) PLZF/RARA   1   1
t(16;21)(p11.2;q22.3) TLS/ERG   1   1
No. of positive cases (%)
   Complex karyotype* 
   Normal karyotype
   Inappropriate specimen
   No mitotic cells 
   Not done
63 (30)
35
108 (3
†)
    5 (5
†)
    1 (1
†)
    1 (1
†)
25 (24)
20
48 (2
†)
10 (9
†)
  1 (1
†)
3 (38)
2
3
91 (28)
57
159 (5
†)
   5 (5
†)
   11 (10
†)
   2 (2
†)
No. of positive cases (%) including  
   FISH results
73 (34) 37 (36) 3 (38) 113 (35)
*Complex karyotypes included chromosome abnormalities including numerical aber-
rations which were not detected by commercial multiplex RT-PCR system; 
†Genetic 
aberrations detected by FISH analysis, which was one of the genetic aberrations in 
28 fusion genes lists.http://jkms.org   889
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detected in 3 BCR/ABL and one MLL1/ELL (Table 3).
Chromosomal aberrations by children and adults 
In the group of children, 53% (43/81) exhibited a positive multi-
plex RT-PCR analysis. Within group of 23 childhood AML pa-
tients, the common cytogenetic abnormalities were 7 AML1/
MGT8, 4 PML/RARA, one TEL/ABL and one patient with both 
BCR/ABL and SET/CAN. The major cytogenetic abnormalities 
in the group of childhood ALL patients (n = 55) were 14 TEL/
AML1, followed by 4 BCR/ABL, 4 E2A/PBX and 3 MLL1/AF4.
  In the group of adult patients, 39% (96/244) had an abnormal 
multiplex RT-PCR analysis. Within the group of 190 adult AML 
patients, the common cytogenetic abnormalities were PML/
RARA (n = 31), followed by AML1/MGT8 (n = 24), CBFB/MYH11 
(n = 3), MLL1/ENL (n = 3) and MLL1/AF6 (n = 2). The common 
cytogenetic abnormalities in the adult ALL patients (n = 49) 
were BCR/ABL (n = 17) and MLL1/AF4 (n = 2) (Supplemental 
Table 1).
Chromosomal aberrations detected by conventional 
karyotyping
In total, cytogenetic analysis was available in 99% of the AML pa-
tients, 99% of the ALL patients and 100% of MPAL. Of the cases, 
97% of AML, 89% of ALL and 100% of MPAL were successfully 
analyzed. Successful cytogenetic analyses were achieved in 307 
(94%) patients, among whom 148 (48%) had detectable clonal 
abnormalities, whereas 159 (52%) were considered cytogeneti-
cally normal. 
  Fourteen types in 28 fusion genes were detected in 35% (113/ 
325) by conventional cytogenetic analysis including FISH. The 
most frequent cytogenetic abnormality was t(15;17)(q21;q22) 
and t(8;21)(q22;q22), detected each in 9% of successful cases, 
followed by t(9;22)(q34;q11) in 7%, t(4;11)(q21.2;q23.2), t(8;14)
(p24.1;q32), +21 each in about 1% (Table 4).
  Within group of 23 childhood AML the common cytogenetic 
abnormalities were t(8;21)(q22;q22) (n = 7), followed by t(15;17)
(q21;q22) (n=3). Within group of 55 childhood ALL the cytoge-
netic abnormalities were t(9;22)(q34;q11) in 3cases, t(4;11)
(q21.2;q23.2) in 2 cases, and t(12:21)(p13;q22), t(1;19)(q23;p13) 
and del(1p34) in 1 case each (Supplemental Table 2). But nor-
mal karyotype was majority in childhood patients with AML 
and ALL. 
  Within group of 190 adult AML the common cytogenetic ab-
normalities were t(15;17)(q21;q22) (n = 25), followed by t(8;21)
(q22;q22) (n = 21). Within group of 49 adult ALL the common 
cytogenetic abnormalities were t(9;22)(q34;q11) (n = 14). Also 
majority of cytogenetic results was normal karyotype (Supple-
mental Table 2).
Table 5. Comparison of genetic aberration detected by multiplex RT-PCR system and 
conventional karyotyping
Comparison Multiplex  
RT-PCR
Conventional  
Karyotyping No. of cases
Concordant  
   70% (228/325)
Positive
Negative
Positive*
extra-aberration
Negative
†
  72
  18
138
Discordant 
   30% (97/325)
Positive
Negative
Negative
Numerical aberration
Inappropriate specimen
No mitotic cells
Not done
Positive
Complex karyotype
Numerical aberration
  21
  10
    5
  11
    2
    1
  15
  32
*Chromosomal abnormality detected by conventional karyotyping; 
†Not detected any 
chromosomal abnormality by conventional karyotyping.
Table 6. Distribution of cytogenetic aberrations which were not detected using multiplex RT-PCR system
Age (yr)/Sex Diagnosis Karyotype  FISH
65/M AML M0 46,XY,t(3;3)(q21;q26.2)
  0/F ALL L1, early pre B-cell  46,XX,t(4;11)(q21;q23)  MLL1
  5/F ALL L3, Burkitt type 46,XX,dup(1)(q25q32),?t(2;12)(p11;q15) 46,XX,?t(2;12)(p11;q15),t(8;14)(q24;q32) 
46,XX,add(1)(p36),?t(2;12)(p11;q15),t(8;14)(q24;q32)
45/F ALL L3, Burkitt type 47,XX,t(8;14)(q24.1;q32),-13,+2mar  MYC/IGH
75/F ALL L3, Burkitt type 50~51,XX,add(6)(q27),+7,+8,t(8;14)(q24.1;q32),+11,+12,+20,+mar  MYC/IGH
51/F AML M7 41~42,X,-X,del(1)(q32),-3,-5,-13,-21,-22,+1~2mar
41~42,XX,del(1)(q32),-3,-5,-13,-21,-22,+1~2mar  
75/M AML M7 43~45,XY,add(1)(p21),-12,-18 46,XY CEP(12)
62/F ALL L2, T-cell  45~46,X,del(X)(q23)[20],add(1)(p36)[20],-8[20],+1~2mar[20] 
53/M AML M5a 46,XY,inv(1)(p13q25) 47,idem,+16
82/F AML M2, Relapse 46~51,XX,add(1)(p3?),+8,+9,+15,+1~3mar 46,XX
  5/M ALL L2, B cell 51~55,XY,dup(1)(q23q42),+4,+8,+10,+12,+21,+22,+1~4mar[20] 
25/F ALL L3, (Burkitt lymphoma variant) 46,XX,add(2)(p25.2), 46,XX, //46,XY
59/M AML M2 46,XY,add(3)(p26)
36/F ALL L1,  early precursor B cell  46,XX,add(4)(q35)46,X,-X,+mar
73/M ALL L2, T cell 47,XY,add(14)(q32),-18,+2mar
12/M AML after u-PBSCT (donor origin)  
R/O Mixed phenotypic acute leukemia, Myeloid/T
46,XY, +8 ,-16, i(17)(q10)890   http://jkms.org
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Table 7. List of chromosomal aberrations covered by multiplex RT-PCR and additional cytogenetic abnormalities in patients with hematological malignancies
Multiplex RT-PCR system* covered leukemic fusion gene detected in this study
t(1;11)(p32;q23) 
t(1;19)(q23;p13) 
t(3;21)(q26;q22) 
t(4;11)(q21;q23) 
t(6;11)(q27;q23) 
t(8;21)(q22;q22) 
t(9;11)(q22;q23) 
t(9;9)(q34;q34) 
t(9;12)(q34;p13) 
t(9;22)(q34;q11) 
MLL1/AF1p  
E2A/PBX1  
AML1/EAP/MDS1/EVI1  
MLL1/AF4  
MLL1/AF6  
AML1/MGT8  
MLL1/AF9  
SET/CAN 
TEL/ABL 
BCR/ABL 
t(10;11)(p12;q23) 
t(11;17)(q23;q21) 
t(11;19)(q23;p13.1) 
t(11;19)(q23;p13.3) 
t(12;21)(p13;q22) 
t(12;22)(p13;q11) 
t(15;17)(q21;q22) 
t(16;21)(p11;q22)  
inv(16)(p13;q22) 
TAL1deletion(p34) 
MLL1/AF10  
PLZF/RARA 
MLL1/ELL
MLL1/ENL
TEL/AML1 
TEL/MN1 
PML/RARA 
TLS/ERG
CBFB/MYH11
SIL1/TAL1 
Multiplex RT-PCR system* did not covered leukemic fusion genes in this study
t(1;11)(q21;q23) 
t(3;5)(q25.1;q34) 
t(5;12)(q33;p13) 
t(5;17)(q35;q21)/(q34;q21) 
MLL1/AF1q  
NPM/MLF1  
TEL/PDGFRB
NPM/RARA  
t(6;9)(p23;q34) 
t(11;17)(q23;q21) 
t(17;19)(q22;p13) 
t(X;11)(q13;23) 
DEK/CAN
MLL1/AF17 
E2A/HLF 
MLL1/AFX1 
Multiplex RT-PCR system* should include leukemic fusion genes based on the current study
t(3;3)(q21;q26.2)
t(8;14)(q24;q32) 
i(17)(q10)
*Commercially available multiplex RT-PCR system for detecting 28 fusion transcripts. 
Comparison of results between the multiplex RT-PCR 
system and conventional cytogenetic analysis
In 228 of 325 patients, there was agreement between the results 
of RT-PCR and conventional karyotyping in 138 of 325 patients, 
no abnormality was detected by either method. In 90/325 (28%) 
patients, a total of 14 fusion transcripts were detected by multi-
plex RT-PCR, in agreement with the karyotype. In a further of 18 
patients (6%), where a specific aberration was demonstrated by 
both methods, the conventional karyotyping revealed addition-
al structural and/or numerical aberrations. The results of multi-
plex RT-PCR system and conventional karyotyping did not agree 
in 97 patients (30%, 97/325). Cytogenetically cryptic transloca-
tions found only in the multiplex RT-PCR system were detected 
in 10% (31/325) patients with a normal karyotype or numerical 
aberrations by conventional cytogenetic analysis. Detailed data 
of comparison between multiplex RT-PCR system and conven-
tional cytogenetics are summarized in Table 5. Forty-eight (26%) 
of 186 patients with a negative result by multiplex RT-PCR anal-
ysis had cytogenetic aberrations in the conventional karyotyp-
ing. In one child case out of the 186 samples, a t(4;11)(q21;q23) 
was detected by conventional karyotyping and verified by FISH, 
while the fusion transcript was not detected by multiplex RT-
PCR analysis (Tables 5, 6). 
Recommended panel for leukemic fusion genes in new 
multiplex RT-PCR systems
In the current study, 35 types of chromosomal abnormalities were 
noticed in 325 patients with hematological malignancies. A com-
mercially available multiplex RT-PCR system for screening 28 
fusion transcripts detected 20 types among them. When exclud-
ing complex and numerical chromosomal abnormalities, 8 types 
of leukemic fusion genes listed in the commercial multiplex RT-
PCR system were not found in our patients (Table 7). Three impor-
tant cytogenetic abnormalities such as t(8;14)(q24; q32), t(3;3)
(q21;q26.2) and i(17)(q10) were also detected in the current study, 
so these chromosomal abnormalities should be included in a 
multiplex RT-PCR system for detecting leukemic fusion genes.
DISCUSSION
Conventional cytogenetic analysis is time-consuming, labor in-
tensive, and has relatively lower sensitivity. In addition, cytoge-
netics reveals enough chromosomal abnormalities and gives 
global information about genetic alterations, but not submicro-
scopic genetic lesions. However, multiplex RT-PCR analysis does 
not require a large amount of patient specimens, can be per-
formed on resting cells, and is very sensitive in detecting rare 
abnormal cells including cryptic genetic aberrations. Thus, it 
should be of great potential benefit to bring the PCR methodol-
ogy up-front in the diagnosis of acute leukemia. But consider-
ing the great number of fusion genes and breakpoint variants 
presently characterized, more than 50 separate PCR reactions 
are needed for the screening of a patient with a standard proce-
dure (1). Recently, a commercially available multiplex-RT-PCR 
system (DNA Technology, Aarhus, Denmark) was introduced 
to detect 28 common leukemic fusion genes and more than 80 
splice variants based on the aforementioned publication (1). Data 
from Denmark using this system which was applied to speci-
mens from 143 patients with a median age of 63 yr (range 0-85 
yr; 132 adults, 11 children) showed that chromosomal rearrange-
ments were detected in only 15% (21/143) of the patients (6). 
However, the current study revealed a higher detection rate (42%) 
with the same multiplex RT-PCR system, with 39% (83/213) in 
AML, 50% in ALL and 50% in MPAL. The spectrum of frequency 
and distribution of leukemic fusion genes in acute leukemia also 
differed from previous European data with a wider range of chro-http://jkms.org   891
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mosomal rearrangements (6). The incidence of leukemia-spe-
cific chromosomal rearrangements in childhood AML disclosed 
57% (13/23) of cases, whereas about 40% (24/60) of childhood 
AML cases had a chromosomal rearrangement using the same 
multiplex RT-PCR system from Austria (7). The detection rate of 
leukemic fusion genes in our ALL patients (50%) showed a high-
er incidence than those from Italian data using the same com-
mercial multiplex RT-PCR system: 53% (29/55) and 47% (23/49) 
of our childhood and adult ALL cases. However, 39% of 170 ALL 
cases harbored leukemic fusion genes from the Italian study: 39% 
and 40% of the childhood and adult ALL cases, respectively (8). 
  The most frequent chromosomal rearrangements in AML pa-
tients in the current study were the t(15;17) abnormality (16%, 
35/213). This incidence was higher when compared with data 
from Caucasian (6.5%-10%), Australian (12%), Japanese (11%) 
and Singapore-Chinese (11%) (9), but similar to the recent Chi-
nese data (14.3%) (10). This discrepancy may be caused by sam-
ple size and possible ethnic differences. The presence of geo-
graphic heterogeneity of cytogenetic abnormalities in hemato-
logical malignancies has required further investigation and a 
better understanding of the genetic and environmental factors 
as etiological factors involved in the development of leukemia. 
As published elsewhere, the frequency and spectrum of chro-
mosomal rearrangements in ALL were similar between the cur-
rent study and previous reports (10, 11). The balanced translo-
cation of BCR/ABL fusion gene in all ALL cases was the most 
prevalent abnormality (20%) in the present study. The incidence 
of BCR/ABL fusion genes disclosed a similar prevalence in the 
Southwest Oncology Group data (26%) (12), but it was higher 
than those from Indian (6%) and Taiwan data (8%) (13, 14). In 
childhood ALL, the most prevalent chromosomal rearrange-
ment was the TEL/AML1 fusion transcript, followed by E2A/
PBX, BCR/ABL and MLL1/AF4. By contrast, in adult ALL, the 
BCR/ABL fusion transcript was the most frequent, followed by 
MLL1 rearrangements, TEL/AML1, and SET/CAN.
  Discordant results between multiplex RT-PCR and conven-
tional cytogenetic analysis were mainly caused by numerical 
and submicroscopic abnormalities. A commercially available 
multiplex RT-PCR system for screening 28 fusion transcripts 
detected 20 types among 35 types of chromosomal abnormalities 
found in 325 patients with hematological malignancies. The con-
cordance rate between the two systems in the current study was 
lower than those of previous studies (6, 7). Due to the location 
of the breakpoints in the telomeric regions of the chromosomes 
and submicroscopic deletions that occur in approximately 20% 
to 30% of such cases, this cryptic translocation is difficult to iden-
tify by conventional cytogenetics (7). In one child case of the 325 
samples in the current study, a t(4;11)(q21;q23) was detected by 
cytogenetics and verified by FISH analysis while the fusion tran-
script was not detected by multiplex RT-PCR analysis.
  Of particular interest are cases with 3 important cytogenetic 
abnormalities such as t(8;14)(q24;q32), t(3;3)(q21;q26.2) and 
i(17)(q10), which were not covered in the commercial multiplex 
RT-PCR system. These chromosomal abnormalities are very im-
portant and representative cytogenetic aberrations in hemato-
logic malignancies including acute leukemia. The t(8;14)(q24; 
q32) is a representative cytogenetic abnormality in ALL (Burkitt 
type) and the t(3;3)(q21;q26.2) is a newly introduced recurrent 
cytogenetic abnormality in AML from 2008 WHO classification. 
The i(17)(q10) is most frequently found in blast crisis of Phila-
delphia-positive CML. The i(17q) as the sole cytogenetic abnor-
mality has also been reported in primary myelofibrosis, hypere-
osinophilic syndrome, and rare cases of myelodysplastic syn-
drome (MDS) and myeloproliferative neoplasm (MPN) that 
evolve into acute non-lymphocytic leukemia. According to sev-
eral reports, MDS/MPN harboring i(17q) as a sole cytogenetic 
abnormality is considered as a unique subset with an incidence 
of 0.4%-1.6% of MDS, or 1% of all myeloid cases, which is char-
acterized by a male predominance, severe anemia, hyposeg-
mented neutrophils, increased micromegakaryocytes and a 
poor prognosis (15, 16). So these chromosomal abnormalities 
should be included in panels for leukemic fusion genes suitable 
for the development of new efficient molecular detection sys-
tems adapted to Korean leukemia patients. 
  In conclusion, the current study demonstrates the spectrum 
and frequency of chromosomal abnormalities in patients with 
mainly acute leukemia, which are differed from previous stud-
ies. Also, this study may offer important implications in the de-
velopment of new molecular detection system for screening 
panel, as well as revisions of the current commercially available 
multiplex RT-PCR system.
REFERENCES
1. Pallisgaard N, Hokland P, Riishøj DC, Pedersen B, Jørgensen P. Multi-
plex reverse transcription-polymerase chain reaction for simultaneous 
screening of 29 translocations and chromosomal aberrations in acute 
leukemia. Blood 1998; 92: 574-88.
2. Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T. 
Further correlations of morphology according to FAB and WHO classifica-
tion to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 
patients. Ann Hematol 2005; 84: 785-91.
3. Betts DR, Ammann RA, Hirt A, Hengartner H, Beck-Popovic M, Kuhne 
T, Nobile L, Caflisch U, Wacker P, Niggli FK. The prognostic significance 
of cytogenetic aberrations in childhood acute myeloid leukaemia. A study 
of the Swiss Paediatric Oncology Group (SPOG). Eur J Haematol 2007; 
78: 468-76.
4. Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. 
Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes 
M0, M1, and M2: a study based on 652 cases analyzed with morphology, 
cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cyto-
genet 2004; 155: 47-56.
5. Look AT. Oncogenic transcription factors in the human acute leukemias. 892   http://jkms.org
Choi H-J, et al.  •  Cytogenetic Aberrations in 325 Leukemia
DOI: 10.3346/jkms.2011.26.7.886
Science 1997; 278: 1059-64.
6. Hutchings Hoffmann M, Wirenfeldt Klausen T, Hasle H, Schmiegelow 
K, Brondum-Nielsen K, Johnsen HE. Multiplex reverse transcription poly-
merase chain reaction screening in acute myeloid leukemia detects cyto-
genetically unrevealed abnormalities of prognostic significance. Haema-
tologica 2005; 90: 984-6.
7. Strehl S, König M, Mann G, Haas OA. Multiplex reverse transcriptase-
polymerase chain reaction screening in childhood acute myeloblastic leu-
kemia. Blood 2001; 97: 805-8.
8. Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M, De 
Rossi G, Foà R, Cimino G. A multiplex reverse transcriptase-polymerase 
chain reaction strategy for the diagnostic molecular screening of chime-
ric genes: a clinical evaluation on 170 patients with acute lymphoblastic 
leukemia. Haematologica 2003; 88: 275-9.
9. Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K, Shiku H, 
Kamada N. Geographic heterogeneity of cellular characteristics of acute 
myeloid leukemia: a comparative study of Australian and Japanese adult 
cases. Leukemia 2000; 14: 163-8.
10. Cheng Y, Wang Y, Wang H, Chen Z, Lou J, Xu H, Qian W, Meng H, Lin M, 
Jin J. Cytogenetic profile of de novo acute myeloid leukemia: a study based 
on 1432 patients in a single institution of China. Leukemia 2009; 23: 1801-6.
11. Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol 2000; 
12: 3-12.
12. Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of 
cytogenetics on the outcome of adult acute lymphoblastic leukemia: re-
sults of Southwest Oncology Group 9400 study. Blood 2008; 111: 2563-72.
13. Amare P, Gladstone B, Varghese C, Pai S, Advani S. Clinical significance 
of cytogenetic findings at diagnosis and in remission in childhood and 
adult acute lymphoblastic leukemia: experience from India. Cancer Gen-
et Cytogenet 1999; 110: 44-53.
14. Chang HH, Lu MY, Jou ST, Lin KH, Tien HF, Lin DT. Cytogenetics in child-
hood acute lymphoblastic leukemia in Taiwan: a single-institutional ex-
perience. Pediatr Hematol Oncol 2006; 23: 495-506.
15. Pinheiro RF, Chauffaille Mde L, Silva MR. Isochromosome 17q in MDS: 
a marker of a distinct entity. Cancer Genet Cytogenet 2006; 166: 189-90.
16. Kim MH, Hwang HY, Jeong SH, Kim YS, Eo WK, Park JS, Moon YH. De-
tection of p53 mutant and isochromosome 17q in myelodysplastic syn-
dromes and leukemias. Korean J Clin Pathol 2000; 20: 349-53.
AUTHOR SUMMARY
Spectra of Chromosomal Aberrations in 325 Leukemia Patients and Implications for 
the Development of New Molecular Detection Systems
Hyun-Jung Choi, Hye-Ran Kim, Myung-Geun Shin, Hoon Kook, Hyeoung-Joon Kim, Jong-Hee Shin, Soon-Pal Suh  
and Dong-Wook Ryang
We investigated the chromosomal abnormalities in 325 patients with acute leukemia. The common cytogenetic aberrations in 
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